Surface oncology, inc. (SURF)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Collaboration revenue - related party

39,518

15,360

24,685

26,071

28,356

59,417

0

0

0

-

-

-

-

Collaboration revenue - related party

-

-

-

-

-

-

-

-

-

-

0

0

0

Operating expenses:
Research and development

49,097

52,118

50,982

53,849

55,711

52,492

58,253

54,571

50,193

47,783

0

0

0

General and administrative

20,302

20,608

20,318

19,311

17,807

16,076

0

0

0

-

-

-

-

General and administrative

-

-

-

-

-

-

-

-

-

-

0

0

0

Total operating expenses

69,399

72,726

71,300

73,160

73,518

68,568

72,337

69,329

63,042

58,816

0

0

0

Income (loss) from operations

-29,881

-57,366

-46,615

-47,089

-45,162

-9,151

-20,205

-16,447

-6,393

-45,990

0

0

0

Interest and other income, net

1,861

2,577

3,045

3,175

3,154

2,554

1,851

1,251

640

613

0

0

0

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

0

0

0

Provision for income taxes

-

-

-

-

-

-

-

-

-

-

0

0

0

Net income (loss)

-28,020

-54,789

-43,570

-43,914

-42,008

-6,597

-17,635

-14,818

-5,539

-45,377

0

0

0

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

11

0

0

0

-

-

-

-

Net income attributable to redeemable convertible preferred stockholders

-

-

-

-

-

-

-

0

0

-

-

-

-

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

-

0

0

0

Net loss attributable to common stockholders

-

-

-16,704

-17,048

-

-6,608

-43,154

0

0

-

0

-

-

Net loss per share attributable to common stockholders—basic and diluted

-

-

-0.61

-

-

-

-0.62

-

-

-

-5.75

-

-

Net (loss) income attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

0

0

Net income (loss) per share attributable to common stockholders— basic

0.81

-

-

-0.64

-0.15

-

-

-0.73

1.59

-

-

-2.73

-3.60

Weighted average common shares outstanding— basic

27,977

-

-

27,845

27,825

-

-

21,595

2,727

-

-

2,413

-

Weighted average common shares outstanding—basic and diluted

-

-

27,862

-

-

-

27,598

-

-

-

2,506

-

2,399

Net income (loss) per share attributable to common stockholders— diluted

0.74

-

-

-0.64

-0.15

-

-

-0.73

1.05

-

-

-2.73

-3.60

Weighted average common shares outstanding— diluted

30,917

-

-

27,845

27,825

-

-

21,595

4,134

-

-

2,413

2,399

Comprehensive income (loss):
Net income (loss)

-28,020

-54,789

-43,570

-43,914

-42,008

-6,597

-17,635

-14,818

-5,539

-45,377

0

0

0

Other comprehensive income (loss):
Unrealized gain on marketable securities, net of tax of $0

165

222

328

407

301

127

0

0

0

-

-

-

-

Unrealized gain on marketable securities, net of tax of $0

-

-

-

-

-

-

-

-

-

-

0

0

0

Comprehensive income (loss)

-27,855

-54,567

-43,242

-43,507

-41,707

-6,470

-17,648

-14,831

-5,575

-45,270

0

0

0